Zobrazeno 1 - 8
of 8
pro vyhledávání: '"S pulicat"'
Gamma H2AX Biodosimetry assay. It can be used to prepare dose response curve.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e2a5cbcce3ad2393efd31202e5ddbda
https://doi.org/10.17504/protocols.io.2xcgfiw
https://doi.org/10.17504/protocols.io.2xcgfiw
Estimation of DNA damage biomarker gamma-H2AX to assess radiation doses received in the event of radiation emergency.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fddb372cb22477256678deafda73a927
https://doi.org/10.17504/protocols.io.2txgepn
https://doi.org/10.17504/protocols.io.2txgepn
Autor:
Abdullah Al-Jefri, Monogaran S. Pulicat, Ameera Gaafar, I Peltekova, Hala Abalkhail, Syed H.E. Zaidi, Muhammad Faiyaz-Ul-Haque, Randa Al-Nounou, Ayodele Alaiya, Ahmed Al-Abdullatif, Jalaluddin A. K. M. Bhuiyan, Fouad Al-Dayel
Publikováno v:
European Journal of Pediatrics. 169:661-666
Autosomal recessive severe congenital neutropenia (SCN) results from a maturation arrest of granulopoiesis at the level of promyelocytes and apoptosis of myeloid cells. In SCN patients, mutations have been described in the HAX1 gene. Most of the SCN
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41c656e624944df9a74f763eb4ea9de1
https://doi.org/10.1007/s00431-010-1150-6
https://doi.org/10.1007/s00431-010-1150-6
Autor:
Syed H.E. Zaidi, A Gaafar, H A Abalkhail, A Al-Jefri, A A Alaiya, M A Al-Muallimi, M S Pulicat, Mohamed Toulimat, Fouad Al-Dayel, I Peltekova, Muhammad Faiyaz-Ul-Haque
Publikováno v:
Clinical Genetics. 76:569-572
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::90432c0c999a5f12f384c00a5063aefd
https://doi.org/10.1111/j.1399-0004.2009.01244.x
https://doi.org/10.1111/j.1399-0004.2009.01244.x
Autor:
Andrew Wetzig, Amer Al-Mazrou, Ayodele Alaiya, Ameera Gaafar, Hazem Ghebeh, Hind Alhumaidan, Zakia Shinwari, Monther Al-Alwan, Imaduddin Kanaan, Chaker N. Adra, Manogaran S Pulicat, Ghida Majed Sleiman, Christian Benedict Pradez
Publikováno v:
BMC Cell Biology
BackgroundMesenchymal stem cells have properties that make them amenable to therapeutic use. However, the acceptance of mesenchymal stem cells in clinical practice requires standardized techniques for their specific isolation. To date, there are no c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caf327fc40614676ee978383120801f3
https://doi.org/10.1186/1471-2121-14-54
https://doi.org/10.1186/1471-2121-14-54
Autor:
Mehar Sultana, Naif A. Al-Jomah, Azhar R. Hussain, Khawla S. Al-Kuraya, Shahab Uddin, Manugaran S. Pulicat
Publikováno v:
Blood. 108:4616-4616
Proteosome inhibition is a novel approach for treating malignancy and has been approved for clinical use. The proteosome is the primary proteolytic mechanism in eukaryotic cells and inhibition of its catalytic activity initiates a cascade of events a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3895174c0894c47dbef28c5bbb2e7d51
https://doi.org/10.1182/blood.v108.11.4616.4616
https://doi.org/10.1182/blood.v108.11.4616.4616
Autor:
Manugaran S. Pulicat, Khaled Al-Hussein, Azhar R. Hussain, Abdul K. Siraj, Shahab Uddin, Naif A. Al-Jomah, Khawla S. Al-Kuraya
Publikováno v:
Blood. 108:4615-4615
Primary effusion lymphoma (PEL) is an aggressive and fatal type of cancer. PEL cells produce a variety of autocrine cytokines and growth factors, which provides cyto-protection against conventional chemotherapeutic agents. In efforts to identify nove
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f7be09b01d7d9714165650c47fb9bbd
https://doi.org/10.1182/blood.v108.11.4615.4615
https://doi.org/10.1182/blood.v108.11.4615.4615